SOPHIA BROWN: Open Payments
NPI 1164838611 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 41 payments from 12 companies in 2025. Trend: 2023 $899 · 2024 $619 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $182 |
| AstraZeneca Pharmaceuticals LP | 6 | $126 |
| Novo Nordisk Inc | 5 | $122 |
| ABBVIE INC. | 5 | $120 |
| Incyte Corporation | 3 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $44 |
| Gilead Sciences, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $30 |
Products named: OTEZLA, OPZELURA, AIRSUPRA, Rybelsus, ZENPEP, Symbravo, UBRELVY, EVENITY.
Industry payments across NY — which companies pay providers there.
